3.300NOK+10.00%Mkt Cap: 81.95M NOKP/E: —Last update: 2026-05-13
Arctic Bioscience AS, a clinical-stage biotechnology company, engages in developing and commercializing pharmaceutical and nutraceutical ingredients based on bioactive marine compounds in Norway, the United States, Europ…
Industry Peers
Biotechnologyloading…
Indicators:|
Key Statistics
Valuation
P/E (Trailing)—
P/E (Forward)-15.20
PEG—
P/B0.47
P/S1.92
EV/EBITDA-4.67
EV/Revenue3.35
EPS (TTM)-1.67
EPS (Forward)-0.20
Cash Flow & Leverage
FCF Yield-44.04%
FCF Margin-84.68%
Operating CF-45.36M NOK
CapEx (TTM)50.81M NOK
Net Debt/EBITDA-1.99
Net Debt61.03M NOK
Technical
SMA 503.325 (-0.7%)
SMA 2003.501 (-5.8%)
Beta1.09
S&P 52W Chg24.23%
Avg Vol (30d)15.64K
Avg Vol (10d)19.84K
Technical Indicators
RSI (14)49.2
MACD-0.0216
MACD Signal-0.0056
MACD Hist.-0.0160
BB Upper3.595 NOK
BB Middle3.346 NOK
BB Lower3.097 NOK
BB Width14.88%
ATR (14)0.2599 NOK
Vol Ratio (20d)0.21x
52W Range
2.62031% of range4.800
52W High4.800 NOK
52W Low2.620 NOK
Profitability
Gross Margin27.34%
EBITDA Margin-71.79%
Profit Margin-110.23%
Oper. Margin-72.20%
ROE-22.75%
ROA-17.13%
Revenue Growth-12.00%
Earnings Growth—
Balance Sheet
Debt/Equity0.16
Current Ratio0.59
Quick Ratio0.24
Book Value/Sh6.436 NOK
Cash/Share0.0480 NOK
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 NOK
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Ownership
Shares Out.26.96M
Float12.89M
Insiders52.25%
Institutions1.44%
Analyst Consensus
Rating0.0 (Hold)
Target (Mean)—
Target Range—
# Analysts—
Company
Market Cap81.95M NOK
Enterprise Value142.98M NOK
Revenue (TTM)42.62M NOK
Gross Profit11.89M NOK
Net Income (TTM)-47.93M NOK
Revenue/Share1.579 NOK
Fiscal Year EndDec 2025
MR QuarterDec 2025
Employees—
Last Price3.300 NOK
CountryNO
SectorHealthcare
IndustryBiotechnology
ISINPLABS0000018